Sleep Apnea Devices Market Report 2025

The sleep apnea devices market size has grown strongly in recent years. It will grow from $7.94 billion in 2024 to $8.43 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to aging population, obesity epidemic, increased recognition of comorbidities, globalization of sleep apnea awareness, prevalence of sleep apnea.

The sleep apnea devices market size is expected to see strong growth in the next few years. It will grow to $11.72 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to advancements in home sleep testing, personalized treatment approaches, increasing adoption of oral appliances, focus on pediatric sleep apnea, patient compliance improvement, emerging markets and increased access. Major trends in the forecast period include telemedicine and remote monitoring, portable and travel-friendly devices, integration of wearable technologies, customization and personalization of therapies, research in implantable devices.

The anticipated growth in the sleep apnea devices market is fueled by the escalating prevalence of sleep apnea disorders. Characterized by recurrent pauses and starts in breathing during sleep, sleep apnea poses potential health risks, making sleep apnea devices crucial for treatment and prevention of sleep disturbances. These devices operate by continuously delivering pressurized air through tubing into a sleep mask, preventing the collapse of the patient's airways. Notably, in April 2022, the American Medical Association (AMA) reported that in the United States alone, 30 million people suffered from sleep apnea. The prevalence of sleep apnea affects one in fifteen Americans, constituting 6.62 percent of the population, with around 30 percent reporting symptoms. Consequently, the rising prevalence of sleep apnea disorders is a key driver for the growth of the sleep apnea device market.

The surge in obesity rates is expected to further propel the expansion of the sleep apnea devices market. Obesity, a medical condition characterized by the excessive accumulation of body fat, poses a significant health threat and is closely linked to sleep apnea. The global increase in obesity rates contributes to the heightened prevalence of sleep apnea, necessitating effective equipment for its management. In March 2022, the World Health Organization (WHO) reported that approximately 1 billion people worldwide, including 650 million adults, 340 million teenagers, and 39 million children, were classified as obese. This number continues to grow, with an estimated 167 million adults and children expected to face health consequences due to overweight or obesity by 2025. Consequently, the upward trend in obesity rates is a driving factor for the sleep apnea device market.

Key companies in the sleep apnea devices market are concentrating on developing innovative devices, such as bi-level positive airway pressure (BiPAP) machines, to enhance patient comfort and improve treatment adherence. BiPAP is a type of non-invasive ventilation primarily used to treat sleep apnea and other respiratory conditions. It provides two levels of pressure: a higher pressure during inhalation (IPAP) to help keep the airway open and a lower pressure during exhalation (EPAP) to facilitate easier breathing out. For example, in February 2024, ResMed, a U.S.-based medical device company, introduced the AirCurve 11 series. This new range of bilevel positive airway pressure (PAP) devices is designed to improve sleep apnea treatment by enhancing patient comfort and encouraging compliance with therapy.

Major players in the sleep apnea devices market are embracing a strategic partnership approach to facilitate home-based sleep apnea detection. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefit. For instance, in May 2023, Signifier Medical Technologies LLC, a US-based medical technology company, announced a partnership with Sunrise, a Hong Kong-based healthcare technology company. This collaboration integrates Sunrise's AI solutions with Signifier Medical's eXciteOSA daytime sleep apnea therapy technologies, enhancing patient care through more efficient diagnosis and treatments. The joint offering includes personalized home sleep testing and a patient management portal, empowering healthcare professionals to gather comprehensive information on patients' daily clinical experiences and optimize outcomes.

In July 2024, EnsoData, a U.S.-based software company, acquired sleep testing diagnostic technology from Resonea for an undisclosed sum. This acquisition is intended to significantly enhance EnsoData's capabilities in screening and diagnosing sleep apnea. The focus of this acquisition is to reduce costs and improve access to systematic screening for sleep apnea. Resonea is a company based in Arizona that specializes in sleep diagnostics.

Major companies operating in the sleep apnea devices market include ResMed Inc., Fisher And Paykel Healthcare Corporation Limited, Natus Medical Incorporated, Compumedics Limited, Somnoware Healthcare Systems Inc., DeVilbiss Healthcare LLC, Braebon Medical Corporation, Koninklijke Philips N.V., BMC Medical Co. Ltd., Lowenstein Medical Technology GmbH Co. KG, Nihon Kohden Corporation, Invacare Corporation, Cadwell Industries Inc., Oventus Medical Ltd., Inspire Medical Systems Inc., Itamar Medical Ltd., APEX Medical Corp., Drive DeVilbiss Healthcare, 3B Medical Inc., Airing LLC, Airway Management Inc., Bleep LLC, Circadiance LLC, GE Healthcare, HOFFRICHTER GmbH, Human Design Medical LLC, ImThera Medical Inc., Provent Sleep Therapy LLC, Resonea Inc., Sleepnet Corporation.

North America was the largest region in the sleep apnea devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global sleep apnea devices market during the forecast period. The regions covered in the sleep apnea devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sleep apnea devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Sleep apnea devices encompass a range of advanced equipment, notably Continuous Positive Airway Pressure (CPAP) machines, designed to mitigate snoring and prevent sleep apnea. These CPAP devices precisely administer optimal air pressure to a mask, ensuring the maintenance of open upper airway passages.

Key categories within the sleep apnea devices market include airway clearance systems, adaptive servo-ventilation (ASV), positive airway pressure (PAP) devices, oral appliances, oxygen devices, sleep screening devices, actuation systems, polysomnography (PSG) devices, and respiratory polygraphs. Airway-clearing systems, a vital component, aid in the expulsion of thick mucus, facilitating coughing or huffing to clear the lungs. This technology is instrumental in addressing conditions such as obstructive sleep apnea syndrome, central sleep apnea syndrome, and complex sleep apnea syndrome. Targeting diverse age demographics, including pediatric, adult, and geriatric populations, these devices find application across various healthcare settings, such as hospitals, clinics, diagnostic centers, ambulatory care centers, specialty care centers, and home healthcare.

The sleep apnea devices market research report is one of a series of new reports that provides sleep apnea devices market statistics, including sleep apnea devices industry global market size, regional shares, competitors with a sleep apnea devices market share, detailed sleep apnea devices market segments, market trends and opportunities, and any further data you may need to thrive in the sleep apnea devices industry. This sleep apnea devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sleep apnea devices market consists of sales of automatic positive airway pressure, biPAP machines, autoPAP machines, positional therapy devices, and implant systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.